Oncovista Innovative Therapies Inc
OTC:OVIT
Cash Flow Statement
Cash Flow Statement
Oncovista Innovative Therapies Inc
| Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||
| Net Income |
(7)
|
(7)
|
(7)
|
(6)
|
(5)
|
(4)
|
(3)
|
(3)
|
10
|
10
|
10
|
10
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
2
|
2
|
2
|
2
|
3
|
2
|
2
|
3
|
(10)
|
(10)
|
(10)
|
(12)
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
0
|
(0)
|
(0)
|
(1)
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
2
|
2
|
2
|
1
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
|
| Cash from Operating Activities |
(4)
N/A
|
(3)
+26%
|
(3)
+11%
|
(2)
+39%
|
(1)
+42%
|
(1)
+36%
|
(1)
+5%
|
(0)
+35%
|
(1)
-54%
|
(1)
-17%
|
(1)
-42%
|
(1)
-60%
|
(2)
-9%
|
(2)
-6%
|
(2)
-5%
|
(2)
+10%
|
(2)
+4%
|
(1)
+11%
|
(1)
+29%
|
(1)
+28%
|
(0)
+34%
|
(0)
+57%
|
(0)
+15%
|
(0)
-17%
|
(0)
-17%
|
(0)
-20%
|
(0)
-14%
|
(0)
+17%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
6
|
0
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+10%
|
(0)
+89%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
6
N/A
|
0
N/A
|
6
N/A
|
6
+4%
|
0
-97%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
(0)
N/A
|
1
N/A
|
1
+36%
|
1
+19%
|
1
+13%
|
0
-64%
|
0
+28%
|
0
-7%
|
(2)
N/A
|
(2)
-5%
|
(2)
-5%
|
(2)
-5%
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
+1%
|
(0)
-1%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
0
N/A
|
0
+55%
|
0
-6%
|
0
-14%
|
|
| Change in Cash | |||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(4)
N/A
|
(3)
+38%
|
(2)
+30%
|
(1)
+64%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
3
+3 695%
|
3
-9%
|
3
-14%
|
2
-13%
|
(1)
N/A
|
(2)
-7%
|
(2)
-6%
|
(2)
-6%
|
(2)
+4%
|
(1)
+11%
|
(1)
+28%
|
(1)
+32%
|
(0)
+34%
|
(0)
+57%
|
(0)
+65%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
+47%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||
| Free Cash Flow |
(4)
N/A
|
(3)
+26%
|
(3)
+11%
|
(2)
+39%
|
(1)
+42%
|
(1)
+36%
|
(1)
+5%
|
(0)
+35%
|
(1)
-54%
|
(1)
-17%
|
(1)
-42%
|
(1)
-60%
|
(2)
-10%
|
(2)
-6%
|
(2)
-5%
|
(2)
+10%
|
(2)
+4%
|
(1)
+11%
|
(1)
+29%
|
(1)
+28%
|
(0)
+34%
|
(0)
+57%
|
(0)
+15%
|
(0)
-17%
|
(0)
-17%
|
(0)
-20%
|
(0)
-14%
|
(0)
+17%
|
|